• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
AGO Recommendations for Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2013.AGO晚期和转移性乳腺癌患者诊断与治疗建议：2013年更新版
Breast Care (Basel). 2013 Jun;8(3):181-5. doi: 10.1159/000353590.
2
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2015.AGO关于晚期和转移性乳腺癌患者诊断与治疗的建议：2015年更新版
Breast Care (Basel). 2015 Jul;10(3):199-205. doi: 10.1159/000431248. Epub 2015 Jun 18.
3
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2016.AGO晚期和转移性乳腺癌患者诊断与治疗建议：2016年更新版
Breast Care (Basel). 2016 Jun;11(3):216-22. doi: 10.1159/000447030. Epub 2016 Jun 15.
4
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2014.AGO晚期和转移性乳腺癌患者诊断与治疗建议：2014年更新版
Breast Care (Basel). 2014 Jul;9(3):202-9. doi: 10.1159/000363551.
5
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019.AGO关于局部晚期和转移性乳腺癌患者诊断与治疗的建议：2019年更新版
Breast Care (Basel). 2019 Aug;14(4):247-255. doi: 10.1159/000500999. Epub 2019 Jul 30.
6
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023.AGO关于局部晚期和转移性乳腺癌患者诊断与治疗的建议：2023年更新版
Breast Care (Basel). 2023 Aug;18(4):306-315. doi: 10.1159/000531579. Epub 2023 Jun 16.
7
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022.AGO关于局部晚期和转移性乳腺癌患者诊断与治疗的建议：2022年更新版
Breast Care (Basel). 2022 Aug;17(4):421-429. doi: 10.1159/000524789. Epub 2022 May 2.
8
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024.妇科肿瘤学工作组：局部晚期和转移性乳腺癌患者的诊断和治疗建议：2024年更新
Breast Care (Basel). 2024 Jun;19(3):183-191. doi: 10.1159/000538753. Epub 2024 Apr 10.
9
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2018.AGO晚期和转移性乳腺癌患者诊断与治疗建议：2018年更新版
Breast Care (Basel). 2018 Jul;13(3):209-215. doi: 10.1159/000489331. Epub 2018 May 22.
10
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2017.AGO关于晚期和转移性乳腺癌患者诊断与治疗的建议：2017年更新版
Breast Care (Basel). 2017 Jul;12(3):184-191. doi: 10.1159/000477576. Epub 2017 Jun 26.

引用本文的文献

1
Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast Cancer.克服激素受体阳性乳腺癌内分泌耐药的靶向治疗
Breast Care (Basel). 2015 Jul;10(3):168-72. doi: 10.1159/000405017. Epub 2015 May 13.
2
Guidelines: usefulness and limitations.指南：用途与局限性。
Breast Care (Basel). 2013 Jun;8(3):172-3. doi: 10.1159/000353791.

本文引用的文献

1
Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study.III 期临床试验评估贝伐珠单抗联合内分泌治疗作为晚期乳腺癌一线治疗的疗效：来曲唑/氟维司群联合阿瓦斯汀（LEA）研究。
J Clin Oncol. 2015 Mar 20;33(9):1045-52. doi: 10.1200/JCO.2014.57.2388. Epub 2015 Feb 17.
2
Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study.依维莫司治疗仅发生骨转移的乳腺癌患者：RADAR 研究的 II 期结果。
J Cancer Res Clin Oncol. 2013 Dec;139(12):2047-56. doi: 10.1007/s00432-013-1518-x. Epub 2013 Sep 27.
3
Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.曲妥珠单抗-美坦新偶联物对比曲妥珠单抗联合多西他赛用于人表皮生长因子受体 2 阳性转移性乳腺癌的 II 期随机研究。
J Clin Oncol. 2013 Mar 20;31(9):1157-63. doi: 10.1200/JCO.2012.44.9694. Epub 2013 Feb 4.
4
Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer.来曲唑联合口服替西罗莫司作为局部晚期或转移性乳腺癌绝经后妇女一线内分泌治疗的随机 III 期安慰剂对照试验。
J Clin Oncol. 2013 Jan 10;31(2):195-202. doi: 10.1200/JCO.2011.38.3331. Epub 2012 Dec 10.
5
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study.拉帕替尼联合卡培他滨治疗人表皮生长因子受体 2 阳性转移性乳腺癌伴未经治疗的脑转移患者（LANDSCAPE）：一项单组、Ⅱ期研究。
Lancet Oncol. 2013 Jan;14(1):64-71. doi: 10.1016/S1470-2045(12)70432-1. Epub 2012 Nov 2.
6
Thermal ablation therapies in patients with breast cancer liver metastases: a review.乳腺癌肝转移患者的热消融治疗：综述。
Eur Radiol. 2013 Mar;23(3):797-804. doi: 10.1007/s00330-012-2662-4. Epub 2012 Oct 13.
7
Trastuzumab emtansine for HER2-positive advanced breast cancer.曲妥珠单抗-美坦新偶联物用于治疗人表皮生长因子受体 2 阳性的晚期乳腺癌。
N Engl J Med. 2012 Nov 8;367(19):1783-91. doi: 10.1056/NEJMoa1209124. Epub 2012 Oct 1.
8
The evolution of the role of surgery in the management of breast cancer lung metastasis.乳腺癌肺转移外科治疗角色的演变。
J Thorac Dis. 2012 Aug;4(4):420-4. doi: 10.3978/j.issn.2072-1439.2012.07.16.
9
Optimal management of malignant pleural effusions (results of CALGB 30102).恶性胸腔积液的最佳管理（CALGB 30102 的结果）。
J Natl Compr Canc Netw. 2012 Aug;10(8):975-82. doi: 10.6004/jnccn.2012.0102.
10
Combination anastrozole and fulvestrant in metastatic breast cancer.阿那曲唑与氟维司群联合治疗转移性乳腺癌。
N Engl J Med. 2012 Aug 2;367(5):435-44. doi: 10.1056/NEJMoa1201622.

AGO Recommendations for Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2013.

作者信息

Harbeck Nadia, Scharl Anton, Thomssen Christoph, Müller Volkmar

机构信息

Brustzentrum, Frauenklinik, Universität München, Hamburg, Germany.

Frauenklinik, Klinikum Amberg, Hamburg, Germany.

出版信息

Breast Care (Basel). 2013 Jun;8(3):181-5. doi: 10.1159/000353590.

DOI:10.1159/000353590
PMID:24415967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3728631/
Abstract
摘要